Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vertex Pharmaceuticals

    NASDAQ: VRTX · Real-Time Price · USD
    392.10
    1.80 (0.46%)
    At close: Aug 15, 2025, 10:13 AM

    Vertex Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 11.02B 9.87B 8.93B 7.57B
    Cost of Revenue
    		 1.53B 1.26B 1.08B 904.2M
    Gross Profit
    		 9.49B 8.61B 7.85B 6.67B
    Operating Income
    		 -232.9M 3.83B 4.31B 2.78B
    Interest Income
    		 598.1M 614.7M 144.6M 4.9M
    Pretax Income
    		 248.5M 4.38B 4.23B 2.73B
    Net Income
    		 -535.6M 3.62B 3.32B 2.34B
    Selling & General & Admin
    		 1.46B 1.14B 944.7M 840.1M
    Research & Development
    		 3.63B 3.16B 2.66B 3.05B
    Other Expenses
    		 4.63B 475.5M -57.5M n/a
    Operating Expenses
    		 9.72B 4.78B 3.54B 3.89B
    Interest Expense
    		 30.6M 44.1M 54.8M 61.5M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 11.25B 6.04B 4.62B 4.79B
    Income Tax Expense
    		 784.1M 760.2M 910.4M 388.3M
    Shares Outstanding (Basic)
    		 257.5M 257.7M 256.1M 257.7M
    Shares Outstanding (Diluted)
    		 257.9M 260.5M 259.1M 259.9M
    EPS (Basic)
    		 -2.08 14.05 12.97 9.09
    EPS (Diluted)
    		 -2.08 13.89 12.82 9.01
    EBITDA
    		 486.3M 4.61B 4.44B 2.92B
    EBIT
    		 279.1M 4.42B 4.29B 2.79B
    Depreciation & Amortization
    		 205.8M 181.3M 148.3M 125.6M

    Add to Watchlist